1 IV Year B.Pharmacy, Ratnam Institute of Pharmacy, Pidathapolour (V), Muthukur (M), SPSR Nellore - 524 346.
2 Department of Pharmaceutics, Ratnam Institute of Pharmacy, Pidathapolour (V), Muthukur (M), SPSR Nellore – 524 346.
3 Department of Pharmacology, Ratnam Institute of Pharmacy, Pidathapolour (V), Muthukur (M), SPSR Nellore – 524 346.
World Journal of Advanced Research and Reviews, 2025, 28(02), 452-464
Article DOI: 10.30574/wjarr.2025.28.2.3704
Received on 26 September 2025; revised on 02 November 2025; accepted on 04 November 2025
Stem cell research represents one of the most transformative fields in modern biomedical science, offering groundbreaking potential in regenerative medicine and disease treatment. Stem cells possess unique self-renewal and differentiation capabilities, allowing them to replace damaged or diseased cells in tissues and organs. Various types of stem cells embryonic, mesenchymal, hematopoietic, neural, induced pluripotent, and tissue-resident play crucial roles in tissue regeneration and therapy development. Their applications span a wide range of medical disciplines, including cardiovascular, neurological, endocrine, metabolic, hepatic, renal, and cancer-related disorders. advances have integrated stem cell technology with innovative approaches such as gene editing (CRISPR-Cas9), organoid formation, and biomaterial scaffolds, significantly enhancing therapeutic precision and clinical translation. Stem cell-based therapies are currently being evaluated in numerous clinical trials for conditions like Parkinson’s disease, diabetes, myocardial infarction, and spinal cord injuries. Moreover, the development of Advanced Therapy Medicinal Products (ATMPs) has provided structured pathways for using gene, cell, and tissue-engineered drugs derived from stem cells.Despite these promising developments, several limitations persist, including tumorigenicity risks, immune rejection, reproducibility challenges, high production costs, and ethical issues, particularly regarding embryonic stem cells. Addressing these barriers through standardized procedures, genetic screening, and ethical frameworks remains essential for clinical success.Looking forward, stem cells are expected to play a pivotal role in personalized medicine by enabling patient-specific therapies tailored to genetic and environmental factors. Collaborative research models, such as the Triple Helix approach linking academia, industry, and government, are vital to accelerating innovation. Overall, stem cell therapy stands as a cornerstone for next-generation medical treatments, holding immense promise for restoring health and improving quality of life worldwide.
Stem Cells;Regenerative Medicine; Organoids; Personalized Medicine
Preview Article PDF
Galanki Praveena, Yerikala Ramesh, Venugopalaiah Penabaka and Yadala Prapurna Chandra. Recent advances in stem cell therapy: Translational applications in regenerative medicine. World Journal of Advanced Research and Reviews, 2025, 28(02), 452-464. Article DOI: https://doi.org/10.30574/wjarr.2025.28.2.3704.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0